Bhalla Narinder Palinsider trades

In SEC Form 4 filings, Bhalla Narinder Pal is listed as Chief Medical Officer of Lexeo Therapeutics, Inc. (LXEO). Bhalla Narinder Pal reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 28.

Companies and roles

Company	Role	Transactions	Last filed
LXEOLexeo Therapeutics, Inc.	Chief Medical Officer	2	Sep 28

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-28

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
LXEOLexeo Therapeutics, Inc.	Sep 24	Sep 28	A · derivative	54,750	$3.39	$185,603	54,750	No	Form 4
LXEOLexeo Therapeutics, Inc.	Sep 14	Sep 28	A	2,714	$3.58	$9,713	84,908	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.